Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Bhatia

Showing results (71-80 of 337) with videos related to

Pageof 34
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 30, 2018
Drug metabolizing enzymes and their inhibitors' role in cancer resistanceShelly Pathania, Rohit Bhatia, Ashish Baldi, et al.
Annals of Indian Academy of Neurology|June 16, 2017
Translation and Adaptation of Stroke Aphasia Depression Questionnaire-10 to HindiHarsimarpreet Kaur, Sakshi Chopra, R M Pandey, et al.
Annals of Indian Academy of Neurology|December 8, 2009
Selective tract abnormality in adrenoleukodystrophy: Uncommon MRI findingRohit Bhatia, Soaham Desai, M V Padma, et al.
Archiv Der Pharmazie|July 8, 2026
Medicinal Insights Into FLT3 Inhibitors as Anticancer Agents: Current Status and Future DirectionAnkush Kumar, Pallvi Kumari, Keshav Raj Paudel, et al.
AAPS Pharmscitech|December 12, 2024
From Bench to Bedside: ROS-Responsive Nanocarriers in Cancer TherapyAbhishek Chauhan, Raj Kamal, Rohit Bhatia, et al.
Current Drug Research Reviews|September 13, 2023
Metabolomics: A Tool to Envisage Biomarkers in Clinical Interpretation of CancerMedha Bhalla, Roopal Mittal, Manish Kumar, et al.
Journal of Neurosciences in Rural Practice|August 3, 2018
Guillain-Barre Syndrome: A Rare Presentation of Borderline Tuberculoid Leprosy with Type 1 Lepra ReactionDeepa Dash, Alvee Saluja, Rajesh Kumar Singh, et al.
Seizure|September 24, 2013
Nurse-led epilepsy follow-up clinic in India: is it feasible and acceptable to patients? A pilot studyPreethy Paul, Meena Agarwal, Rohit Bhatia, et al.
Anti-Cancer Agents in Medicinal Chemistry|October 27, 2018
Enasidenib: First Mutant IDH2 Inhibitor for the Treatment of Refractory and Relapsed Acute Myeloid LeukemiaRaghav Dogra, Rohit Bhatia, Ravi Shankar, et al.
Neurobiology of Aging|June 14, 2018
Targeted next-generation sequencing reveals novel and rare variants in Indian patients with amyotrophic lateral sclerosisPriyam Narain, Ashutosh Pandey, Shruti Gupta, et al.
Pageof 34

Showing results (71-80 of 337) with videos related to

Sort By:
Pageof 34
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 30, 2018
Drug metabolizing enzymes and their inhibitors' role in cancer resistanceShelly Pathania, Rohit Bhatia, Ashish Baldi, et al.
Annals of Indian Academy of Neurology|June 16, 2017
Translation and Adaptation of Stroke Aphasia Depression Questionnaire-10 to HindiHarsimarpreet Kaur, Sakshi Chopra, R M Pandey, et al.
Annals of Indian Academy of Neurology|December 8, 2009
Selective tract abnormality in adrenoleukodystrophy: Uncommon MRI findingRohit Bhatia, Soaham Desai, M V Padma, et al.
Archiv Der Pharmazie|July 8, 2026
Medicinal Insights Into FLT3 Inhibitors as Anticancer Agents: Current Status and Future DirectionAnkush Kumar, Pallvi Kumari, Keshav Raj Paudel, et al.
AAPS Pharmscitech|December 12, 2024
From Bench to Bedside: ROS-Responsive Nanocarriers in Cancer TherapyAbhishek Chauhan, Raj Kamal, Rohit Bhatia, et al.
Current Drug Research Reviews|September 13, 2023
Metabolomics: A Tool to Envisage Biomarkers in Clinical Interpretation of CancerMedha Bhalla, Roopal Mittal, Manish Kumar, et al.
Journal of Neurosciences in Rural Practice|August 3, 2018
Guillain-Barre Syndrome: A Rare Presentation of Borderline Tuberculoid Leprosy with Type 1 Lepra ReactionDeepa Dash, Alvee Saluja, Rajesh Kumar Singh, et al.
Seizure|September 24, 2013
Nurse-led epilepsy follow-up clinic in India: is it feasible and acceptable to patients? A pilot studyPreethy Paul, Meena Agarwal, Rohit Bhatia, et al.
Anti-Cancer Agents in Medicinal Chemistry|October 27, 2018
Enasidenib: First Mutant IDH2 Inhibitor for the Treatment of Refractory and Relapsed Acute Myeloid LeukemiaRaghav Dogra, Rohit Bhatia, Ravi Shankar, et al.
Neurobiology of Aging|June 14, 2018
Targeted next-generation sequencing reveals novel and rare variants in Indian patients with amyotrophic lateral sclerosisPriyam Narain, Ashutosh Pandey, Shruti Gupta, et al.
Pageof 34